Impaired immune reconstitution post sequential high-dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.

被引：0
|
作者：
Stein, DT
Mackall, CL
Bare, CV
Brown, MR
Carter, CS
Casey, N
Yu, MY
Fleisher, TA
Leitman, SF
Shearer, GM
Wexler, L
Gress, RE
机构：
[1] NCI,DEPT TRANSFUS MED,BETHESDA,MD 20892
[2] NIH,DEPT CLIN PATHOL,BETHESDA,MD 20892
来源：
PEDIATRIC RESEARCH | 1996年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：962 / 962
页数：1
相关论文
共 50 条
  • [41] High-dose sequential chemotherapy supported by peripheral blood progenitor cells for the treatment of small cell lung cancer: Results of the EBMT RandomICE trial
    Leyvraz, S.
    Pampallona, S.
    Martinelli, G.
    Ploner, F.
    Aversa, S.
    Brunsvig, P.
    Montes, A.
    Lange, A.
    Yilmaz, U.
    Rosti, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S16 - S17
  • [42] Clinical adverse events during cryopreserved peripheral blood progenitor cell (PBPC) infusion
    Insunza, A
    Romon, I
    Gonzalez-Ponte, L
    Hermosa, V
    TRANSFUSION, 2004, 44 (09) : 55A - 55A
  • [43] Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy
    Glaspy, JA
    BONE MARROW TRANSPLANTATION, 1999, 23 (Suppl 2) : S21 - S27
  • [44] Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy
    John A Glaspy
    Bone Marrow Transplantation, 1999, 23 : S21 - S27
  • [45] Tandem cycle high-dose chemotherapy (HDCT) of melphalan (MEL) and busulfan/cyclophosphamide (BU/CY) with peripheral blood progenitor cell rescue (PBPC) in multiple myeloma (MM).
    Somlo, G
    Snyder, D
    Brown, A
    Dagis, A
    Nademanee, A
    ODonnell, M
    Parker, P
    Stein, A
    Smith, E
    Molina, A
    Spielberger, R
    Margolin, K
    Planas, I
    Kashyap, A
    Chow, W
    Fung, H
    Bhatia, R
    Forman, SJ
    BLOOD, 1997, 90 (10) : 1709 - 1709
  • [46] High-dose chemotherapy followed by autologous peripheral blood progenitor cell rescue in patients with germ-cell tumors
    Nepomucká, J
    Boubliková, L
    Charvát, J
    Simková, V
    Kalanin, J
    Greplová, M
    Bartová, M
    Lukásová, M
    Abrahámová, J
    BONE MARROW TRANSPLANTATION, 1999, 23 : S192 - S192
  • [47] Short and high dose of lenograstim permits peripheral blood progenitor cell collection (PBPC) in patients with AML
    Boogaerts, MA
    vanPutten, W
    Ferrant, A
    Ossenkoppele, G
    Dekker, AW
    Vellenga, E
    Hagenbeek, A
    Wijemans, P
    Fey, MJ
    Gratwohl, A
    Lowenberg, B
    BLOOD, 1995, 86 (10) : 3910 - 3910
  • [48] Experiences in sequential high dose chemotherapy (HDCT) supported by G-CSF mobilized peripheral blood progenitor cells (PBPC) in advanced ovarian cancer
    Wandt, H
    Birkmann, J
    Schaefer-Eckart, K
    Denzel, T
    Both, A
    Egger, H
    Gallmeier, WM
    BONE MARROW TRANSPLANTATION, 1998, 22 : S9 - S9
  • [49] High-dose chemotherapy with four drugs and peripheral blood progenitor cell autologous transplantation in disseminated breast cancer
    Martin, M
    Casado, A
    Llorente, L
    Martin, JAL
    Lescure, AR
    Nieto, Y
    Ayala, F
    Calvo, JP
    Alonso, JL
    Lopez, CP
    Villegas, A
    Diaz-Rubio, E
    MEDICINA CLINICA, 1997, 109 (20): : 775 - 781
  • [50] High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Hohaus, S
    Engenhart, R
    Wannenmacher, M
    Haas, R
    ANNALS OF ONCOLOGY, 1997, 8 (03) : 243 - 246
12345